UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of August 2026
Commission File Number: 001-42795
DarkIris Inc.
(Registrant’s Name)
6/F, Cheong Sun Tower
No. 118 Wing Lok Street
Sheung Wan, Hong Kong
(Address of Principal Executive Offices)
Indicate by check mark... (continue reading...)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 13, 2026
MeiraGTx Holdings plc
(Exact name of registrant as specified in its charter)
Cayman Islands
001-38520
98-1448305
(State or other jurisdiction of incorporation or organization)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
Filed by the Registrant ☒
Filed by a party other than the Registrant ☐
Check the appropriate box:
☐ Preliminary Proxy Statement
☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
☐ Definitive Proxy Statement
More SEC Filings
View Older Stories-
Form 8-K Elmet Group Co. For: Aug 13
-
Form 4 Cellebrite DI Ltd. For: Aug 12 Filed by: GEE DAVID NICHOLAS
-
Form 4 DORIAN LPG LTD. For: Aug 11 Filed by: Hansen Tim Truels
-
Form 6-K Xunlei Ltd For: Aug 13
-
Form PRE 14A YHN Acquisition I Ltd For: Sep 14
-
Form N-PX CHEVRON CORP For: Jun 30
-
Form 13F-HR CHEVRON CORP For: Jun 30
-
Form 8-K MONRO, INC. For: Aug 11
-
Form 10-Q Bit Digital, Inc For: Jun 30
-
Form 8-K Grace Therapeutics, Inc. For: Aug 13
-
Form 10-Q Amanat Acquisition Corp. For: Jun 30
-
Form SCHEDULE 13G Cartesian Growth Corp Filed by: CGC IV Sponsor LLC
-
Form 10-Q Maitong Sunshine Cultura For: Jun 30
-
Form 10-Q Aimei Health Technology For: Jun 30
-
Form 8-K Venu Holding Corp For: Aug 13
-
Form 8-K Artius II Acquisition For: Aug 13
-
Form 8-K HEALTHY CHOICE WELLNESS For: Aug 07
-
Form 8-K Rekor Systems, Inc. For: Aug 13
-
Form 8-K SCI Engineered Materials For: Aug 13
-
Form 424B5 VEEA INC.
-
Form 6-K Radiopharm Theranostics For: Aug 13
-
Form 13F-HR SOUTH PLAINS FINANCIAL, For: Jun 30
-
Form SCHEDULE 13G/A Alpha Metallurgical Reso Filed by: PABRAI MOHNISH
-
Form DEFA14A Accelerant Holdings
-
Form 6-K PLDT Inc. For: Aug 13
-
Form 25-NSE Babcock & Wilcox Enterpr Filed by: NEW YORK STOCK EXCHANGE LLC
-
Form 8-K Accelerant Holdings For: Aug 13
-
Form 13F-HR COMPASS CAPITAL CORP For: Jun 30
-
Form 8-K Bluejay Diagnostics, For: Aug 13
-
Form 6-K Ascendis Pharma A/S For: Jun 30
-
Form 144 SILICOM LTD. Filed by: Eizenman Liron
-
Form 424B3 1st FRANKLIN FINANCIAL
-
Form 13F-HR GAM Holding AG For: Mar 31
-
Form 6-K Kanzhun Ltd For: Aug 13
-
Form 424B3 1st FRANKLIN FINANCIAL
-
Form SCHEDULE 13G THOR INDUSTRIES INC Filed by: Life Cycle Investment Partners Ltd
-
Form 13F-HR Dalal Street, LLC For: Jun 30
-
Form 13F-HR L1 Capital Pty Ltd For: Jun 30
-
Form 497J Tidal Trust II
-
Form D WEBULL EX INC
-
Form 8-K IREN Ltd For: Aug 13
-
Form 13F-HR L1 Capital International For: Jun 30
-
Form 13F-HR Evolutionary Tree Capita For: Jun 30
-
Form 10-Q Pyxis Oncology, Inc. For: Jun 30
-
Form 8-K Pyxis Oncology, Inc. For: Aug 13
-
Form 10-Q Karyopharm Therapeutics For: Jun 30
-
Form 8-K MiNK Therapeutics, Inc. For: Aug 13
-
Form 8-K Madison Square Garden For: Aug 13
-
Form 8-K CREATIVE REALITIES, INC. For: Aug 13
-
Form 6-K Arcos Dorados Holdings For: Aug 13
